A COMPARATIVE ASSESSMENT OF CLINICAL AND BIOCHEMICAL MARKERS OF METABOLIC SYNDROME IN PATIENTS WITH AND WITHOUT NON-ALCOHOLIC FATTY LIVER DISEASE

Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is an escalating public health issue and is commonly recognized as the hepatic aspect of metabolic syndrome (MetS). Metabolic syndrome is defined by central obesity, insulin resistance, dyslipidemia, and hypertension.